Skip to main content
. 2015 Nov 3;33(2):429–441. doi: 10.1093/molbev/msv235

Table 1.

MICs in mg/l of Variants Leading to SHV-129 with a Variety of β-Lactams and Inhibitors.

AMP THIN CAZ TAX FEP AZT AMP-CLAVa AMP-SULa AMP-TAZOa
Escherichia coli DH10B empty 0.5 4–8 <0.06 <0.06 <0.06 <0.06 0.12 0.12 0.12
SHV-1 >16,384 256 4 0.12 1 0.12 8 512 64
SHV-2 (G238S) 4,096 >512 16 16–32 4 1 0.5 16 8
E240K >16,384 128 16 0.12 0.5 0.12–0.25 4 256 64
SHV-5 (G238S-E240K) 1,024 >512 >32 32 4 32 0.5 16 8
R275L >16,384 256 4 0.12 0.12 0.12 2 128 16
N276D 16,384 32 4 0.12 1 <0.06 16 256 64
R275L-N276D 8,192 32 4 <0.06 1 <0.06 4 128 32
G238S-E240K-R275L 2,048–4,096 >512 >32 16–32 8 >32 0.25 8 8
G238S-E240K-N276D 2,048–4,096 >512 >32 16 8 >32 0.5 8 8
SHV-129 (G238S-E240K-R275L-N276D) 2,048–4,096 512 >32 4 16 32 0.5 8 8
T182M 8,192–16,384 32 0.12 <0.06 0.12 0.12 0.5 ND ND

Note.—AMP = ampicillin; THIN = cephalothin; CAZ = ceftazidime; FEP = cefepime; AZT = aztreonam; CLAV = clavulanic acid; SUL = sulbactam; TAZO = tazobactam; ND = not determined.

aInhibitor held constant at 4 mg/l and ampicillin concentration increased in doubling dilutions.